Structure, development, preclinical and clinical efficacy of blinatumomab in acute lymphoblastic leukemia.

about

Recent advances and novel treatment paradigms in acute lymphocytic leukemia Oligoclonality and new agent evaluation in acute lymphoblastic leukaemia.

P2860

Q28078076-E13706C3-A3D9-4D4E-90B3-913168D7E434 Q38843371-A147619C-8537-4B52-B3F6-40BFA036E0CB

P2860

Structure, development, preclinical and clinical efficacy of blinatumomab in acute lymphoblastic leukemia.

Item

http://www.wikidata.org/entity/Q38527924

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Structure, development, precli ...... acute lymphoblastic leukemia.

@en

type

Item

label

Structure, development, precli ...... acute lymphoblastic leukemia.

@en

prefLabel

Structure, development, precli ...... acute lymphoblastic leukemia.

@en

P1476

Structure, development, precli ...... acute lymphoblastic leukemia.

@en

P2093

Anjali S Advani

http://www.w3.org/2001/XMLSchema#string

Naresh Bumma

http://www.w3.org/2001/XMLSchema#string

Nikolaos Papadantonakis

http://www.w3.org/2001/XMLSchema#string

P2860

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

Cancer statistics, 2014

CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy

Tumor regression in cancer patients by very low doses of a T cell-engaging antibody

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia

Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801.

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.

SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia

Extremely potent, rapid and costimulation-independent cytotoxic T-cell response against lymphoma cells catalyzed by a single-chain bispecific antibody.

Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia.

P304

1729-1739

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON.15.84

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

278330751

http://www.w3.org/2001/XMLSchema#string

P698

26075441

http://www.w3.org/2001/XMLSchema#string

Structure, development, preclinical and clinical efficacy of blinatumomab in acute lymphoblastic leukemia.

about

P2860

P2860

Structure, development, preclinical and clinical efficacy of blinatumomab in acute lymphoblastic leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698